1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with pituitrin in 24 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (pituitrin) | Trials (pituitrin) | Recent Studies (post-2010) (pituitrin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 22,137 | 594 | 2,101 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (75.00) | 18.7374 |
1990's | 4 (16.67) | 18.2507 |
2000's | 2 (8.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clarkson, WD; Heemskerk, JW; Sage, SO; Sargeant, P | 1 |
Gandhi, CR; Olson, MS | 1 |
Baldenkov, GN; Grigorian, GIu; Mazaev, AV; Negresku, EV; Tkachuk, VA | 1 |
Brass, LF; Manning, DR; Woolkalis, MJ | 1 |
Avdonin, PV; Kravchenko, AN; Men'shikov, MIu; Nekrasova, AA; Shkhvatsabaia, IK | 1 |
Hackenthal, E; Taugner, R | 1 |
Bühler, FR; Dimitrov, D; Resink, TJ; Stucki, S | 1 |
Drummond, AH; MacIntyre, DE; McNicol, A | 1 |
Bushfield, M; MacIntyre, DE; MacMillan, LJ; McNicol, A; Pollock, WK; Shaw, AM | 1 |
Bushfield, M; MacIntyre, DE; MacMillan, LJ; McNicol, A; Moffat, KJ; Murdoch, FA; Rossi, AG; Thomson, A | 1 |
Alexandre, A; Deana, R; Doni, MG; Padoin, E | 1 |
Aarhus, LL; Shimokawa, H; Vanhoutte, PM | 1 |
Rink, TJ; Sage, SO | 1 |
Schwertschlag, US; Whorton, AR | 1 |
Lapetina, EG; Siess, W | 1 |
Conrad, GW; Rink, TJ | 1 |
Hardisty, RM; Powling, MJ | 1 |
García-Sáinz, JA; Hernández-Sotomayor, SM | 1 |
Aglietta, M; Bussolino, F; Camussi, G; Malavasi, F; Piacibello, W; Sanavio, F; Tetta, C | 1 |
Barth, T; Bekemeier, H; Hänsel, F; Hirschelmann, R; Sänze, JU | 1 |
Buckalew, VM; Handa, RK; Strandhoy, JW | 1 |
Bailly, C; Imbert-Teboul, M; Néant, F | 1 |
Egresits, J; Kordás, K; László, F; László, FA; Morschl, E; Nemcsik, J; Pávó, I | 1 |
Frey, M; Herndon, DH; Jeschke, MG; Kamolz, LP; Keck, M | 1 |
3 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pituitrin
Article | Year |
---|---|
Hormonal signals and intracellular messengers for renin secretion.
Topics: Acetylcholine; Adenosine; Adenylyl Cyclases; Adrenergic alpha-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cyclic AMP; Cyclic GMP; Dopamine; Epinephrine; Histamine; Hormones; Nerve Tissue Proteins; Neuropeptide Y; Norepinephrine; Platelet Activating Factor; Prostaglandins; Renin; Vasopressins | 1986 |
Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
Topics: Adenosine; Adenosine Diphosphate; Blood Platelets; Epinephrine; Epoprostenol; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin D2; Prostaglandins D; Receptors, Cell Surface; Serotonin; Structure-Activity Relationship; Thrombin; Thromboxane A2; Vasopressins | 1986 |
Pathophysiology of burns.
Topics: Angiotensin II; Animals; Burns; Catecholamines; Edema; Hemodynamics; Histamine; Humans; Hypovolemia; Inflammation Mediators; Platelet Activating Factor; Prostaglandins; Serotonin; Skin; Soft Tissue Injuries; Thromboxanes; Vascular Resistance; Vasopressins | 2009 |
21 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pituitrin
Article | Year |
---|---|
Calcium influx evoked by Ca2+ store depletion in human platelets is more susceptible to cytochrome P-450 inhibitors than receptor-mediated calcium entry.
Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Calcium Channels; Calcium-Transporting ATPases; Cell Compartmentation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Econazole; Humans; Hydroquinones; Inositol 1,4,5-Trisphosphate; Intracellular Fluid; Ion Channel Gating; Manganese; Miconazole; Osmolar Concentration; Platelet Activating Factor; Platelet Activation; Receptors, Cholinergic; Ryanodine Receptor Calcium Release Channel; Signal Transduction; Terpenes; Thapsigargin; Thrombin; Vasopressins | 1992 |
PAF effects on transmembrane signaling pathways in rat Kupffer cells.
Topics: Animals; Bradykinin; Calcium; Cell Membrane; Cells, Cultured; Cholera Toxin; Egtazic Acid; Inositol Phosphates; Kupffer Cells; Liver; Male; Models, Biological; Nifedipine; Norepinephrine; Pertussis Toxin; Phosphatidylinositols; Platelet Activating Factor; Prostaglandins; Rats; Rats, Inbred Strains; Signal Transduction; Vasopressins; Virulence Factors, Bordetella | 1991 |
[Biochemical features of platelet alpha2-adrenergic receptors and their connection with an increase in concentration of intracellular Ca2+].
Topics: Blood Platelets; Calcium; Cyclic AMP; Depression, Chemical; Epinephrine; Humans; Norepinephrine; Phentolamine; Platelet Activating Factor; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Serotonin; Stimulation, Chemical; Vasopressins; Yohimbine | 1989 |
Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase.
Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Blood Platelets; Cell Membrane; Cyclic AMP; Epoprostenol; GTP-Binding Proteins; Humans; Peptide Mapping; Pertussis Toxin; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Type C Phospholipases; Vasopressins; Virulence Factors, Bordetella | 1988 |
[Receptor-dependent regulation of the concentration of Ca2+ in the cytoplasm of thrombocytes in hypertensive patients].
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Calcium; Cytoplasm; Humans; Hypertension; Male; Middle Aged; Platelet Activating Factor; Receptors, Cell Surface; Vasopressins | 1988 |
The influence of activating hormones on human platelet membrane Ca2+-ATPase activity.
Topics: Adenosine Diphosphate; Alprostadil; Blood Platelets; Calcimycin; Calcium-Transporting ATPases; Cell Membrane; Colforsin; Ethers; Humans; Ionomycin; Kinetics; Platelet Activating Factor; Tetradecanoylphorbol Acetate; Thrombin; Vasopressins | 1986 |
Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca2+ flux in human platelets.
Topics: Blood Platelets; Calcium; Carcinogens; Enzyme Activation; Humans; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phorbols; Phosphatidylinositols; Platelet Activating Factor; Protein Kinase C; Protein Kinases; Tetradecanoylphorbol Acetate; Thrombin; Vasopressins | 1985 |
Agonist-induced inositol phospholipid metabolism and Ca++ flux in human platelet activation.
Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Epinephrine; Humans; Kinetics; Phosphatidic Acids; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Serotonin; Thrombin; Vasopressins | 1985 |
Inhibition by antioxidants of agonist evoked cytosolic Ca++ increase, ATP secretion and aggregation of aspirinated human platelets.
Topics: Adenosine Triphosphate; Antioxidants; Aspirin; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Calcium; Egtazic Acid; Ferrous Compounds; Humans; Masoprocol; Organometallic Compounds; Platelet Activating Factor; Platelet Aggregation; Tetradecanoylphorbol Acetate; Thrombin; Vasopressins | 1986 |
Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin.
Topics: Adenosine Diphosphate; Animals; Calcimycin; Coronary Circulation; Coronary Vessels; Endothelium; In Vitro Techniques; Male; Microscopy, Electron; Muscle Contraction; Muscle, Smooth, Vascular; Nitroprusside; Platelet Activating Factor; Platelet Aggregation; Regeneration; Serotonin; Swine; Thrombin; Vasopressins | 1987 |
The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets.
Topics: Adenosine Diphosphate; Benzofurans; Blood Platelets; Calcium; Colforsin; Dose-Response Relationship, Drug; Egtazic Acid; Fluorometry; Fura-2; Humans; Kinetics; Nickel; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Thrombin; Vasopressins | 1987 |
Platelet-activating factor-induced homologous and heterologous desensitization in cultured vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Benzofurans; Calcium; Cells, Cultured; Cytosol; Diglycerides; Fluorescent Dyes; Fura-2; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Male; Muscle, Smooth, Vascular; Platelet Activating Factor; Rats; Rats, Inbred Strains; Spectrometry, Fluorescence; Tetradecanoylphorbol Acetate; Vasopressins | 1988 |
Phorbol esters sensitize platelets to activation by physiological agonists.
Topics: Adenosine Diphosphate; Alprostadil; Collagen; Humans; Kinetics; Phorbol Esters; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Structure-Activity Relationship; Vasopressins | 1987 |
Platelet activating factor raises intracellular calcium ion concentration in macrophages.
Topics: Animals; Cadmium; Calcium; Collagen; Cytoplasm; In Vitro Techniques; Macrophages; Manganese; Mice; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Vasopressins | 1986 |
Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+.
Topics: Adenosine Triphosphate; Aminoquinolines; Blood Platelets; Calcium; Cytosol; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Tetradecanoylphorbol Acetate; Thrombin; Vasopressins | 1986 |
Stimulation of hepatic glycogenolysis by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) via cyclooxygenase products.
Topics: Acetophenones; Animals; Female; Glucose; Indomethacin; Liver Glycogen; Perfusion; Phorbols; Phospholipases A; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Strains; Tetradecanoylphorbol Acetate; Vasopressins | 1985 |
The release of platelet-activating factor from human endothelial cells in culture.
Topics: Angiotensin II; Animals; Calcimycin; Cells, Cultured; Chemical Phenomena; Chemistry, Physical; Endothelium; Factor VIII; Humans; Platelet Activating Factor; Rabbits; Umbilical Veins; Vasopressins | 1983 |
On the nature of the vasoreactivity depressing factor (VDF) in inflammation and anaphylaxis in the rat and mouse.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Alprostadil; Anaphylaxis; Animals; Anti-Inflammatory Agents; Epoprostenol; Female; Histamine; Indomethacin; Inflammation; Male; Mice; Mice, Inbred Strains; Norepinephrine; Platelet Activating Factor; Prostaglandins E; Pyrazoles; Rats; Rats, Inbred Strains; Serotonin; Vasopressins | 1984 |
Effects of phospholipids on renal function.
Topics: Angiotensin II; Animals; Arginine; Diuresis; Dogs; Hemodynamics; Kidney; Lysophosphatidylcholines; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Platelet Activating Factor; Rats; Renal Artery; Renal Circulation; Structure-Activity Relationship; Vasodilation; Vasopressins | 1993 |
Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Calcium; Chlorides; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Isoquinolines; Kidney Medulla; Kinetics; Loop of Henle; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Parathyroid Hormone; Platelet Activating Factor; Protein Kinase C; Time Factors; Vasopressins | 1994 |
Synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats.
Topics: Angina Pectoris; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Diterpenes; Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Epinephrine; Ginkgolides; Heart Rate; Hormone Antagonists; Injections, Intravenous; Lactones; Male; Myocardial Ischemia; Ornipressin; Phentolamine; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Vasopressin; Time Factors; Vasoconstrictor Agents; Vasopressins | 2004 |